Terracciano S - Search Results

1

Hsp90 Activity Modulation by Plant Secondary Metabolites.

Dal Piaz F, Terracciano S, De Tommasi N, Braca A. Dal Piaz F, et al. Among authors: terracciano s. Planta Med. 2015 Sep;81(14):1223-39. doi: 10.1055/s-0035-1546251. Epub 2015 Jul 30. Planta Med. 2015. PMID: 26227505 Review.

2

Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold.

Strocchia M, Terracciano S, Chini MG, Vassallo A, Vaccaro MC, Dal Piaz F, Leone A, Riccio R, Bruno I, Bifulco G. Strocchia M, et al. Among authors: terracciano s. Chem Commun (Camb). 2015 Mar 4;51(18):3850-3. doi: 10.1039/c4cc10074c. Chem Commun (Camb). 2015. PMID: 25656927

3

Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors.

Terracciano S, Chini MG, Piaz FD, Vassallo A, Riccio R, Bruno I, Bifulco G. Terracciano S, et al. Eur J Med Chem. 2013 Jul;65:464-76. doi: 10.1016/j.ejmech.2013.05.016. Epub 2013 May 23. Eur J Med Chem. 2013. PMID: 23770448

4

Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain.

Terracciano S, Russo A, Chini MG, Vaccaro MC, Potenza M, Vassallo A, Riccio R, Bifulco G, Bruno I. Terracciano S, et al. Sci Rep. 2018 Jan 26;8(1):1709. doi: 10.1038/s41598-017-14902-y. Sci Rep. 2018. PMID: 29374167 Free PMC article.

5

Discovery of new potent molecular entities able to inhibit mPGES-1.

Di Micco S, Terracciano S, Cantone V, Fischer K, Koeberle A, Foglia A, Riccio R, Werz O, Bruno I, Bifulco G. Di Micco S, et al. Among authors: terracciano s. Eur J Med Chem. 2018 Jan 1;143:1419-1427. doi: 10.1016/j.ejmech.2017.10.039. Epub 2017 Oct 23. Eur J Med Chem. 2018. PMID: 29133047

6

Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).

Lauro G, Strocchia M, Terracciano S, Bruno I, Fischer K, Pergola C, Werz O, Riccio R, Bifulco G. Lauro G, et al. Among authors: terracciano s. Eur J Med Chem. 2014 Jun 10;80:407-15. doi: 10.1016/j.ejmech.2014.04.061. Epub 2014 Apr 24. Eur J Med Chem. 2014. PMID: 24794772

7

Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein.

Ruggiero D, Terracciano S, Lauro G, Pecoraro M, Franceschelli S, Bifulco G, Bruno I. Ruggiero D, et al. Among authors: terracciano s. Molecules. 2022 Jan 20;27(3):665. doi: 10.3390/molecules27030665. Molecules. 2022. PMID: 35163936 Free PMC article.

8

Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics.

Terracciano S , Lauro G , Russo A , Vaccaro MC , Vassallo A , De Marco M , Ranieri B , Rosati A , Turco MC , Riccio R , Bifulco G , Bruno I . Terracciano S , et al. Chem Commun (Camb). 2018 Jul 5;54(55):7613-7616. doi: 10.1039/c8cc03399d. Chem Commun (Camb). 2018. PMID: 29926854

9

Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors.

Terracciano S, Chini MG, Vaccaro MC, Strocchia M, Foglia A, Vassallo A, Saturnino C, Riccio R, Bifulco G, Bruno I. Terracciano S, et al. Chem Commun (Camb). 2016 Oct 25;52(87):12857-12860. doi: 10.1039/c6cc06379a. Chem Commun (Camb). 2016. PMID: 27731433

10

Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity.

Botta A, Sirignano E, Popolo A, Saturnino C, Terracciano S, Foglia A, Sinicropi MS, Longo P, Di Micco S. Botta A, et al. Among authors: terracciano s. Mol Inform. 2015 Oct;34(10):689-97. doi: 10.1002/minf.201500043. Epub 2015 Jul 1. Mol Inform. 2015. PMID: 27490969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page